Momenta Pharmaceuticals, Inc. (MNTA)

[go seek]

Agree, the 2 messages sent by Teva do not add up.

1. 8 Nov WSJ article:
(Teva PR) met in Oct with FDA - "application stuck in bureaucratic limbo"

2. 2 Nov Teva earnings call:
(BM)"On the enoxaparin, there isn't a whole lot more color to add to enoxaparin other than what I think is important is we achieved chemical sameness and we're in review with OPD, and meeting with management helped us feel much better about the situation... I'd be deeply disappointed if we didn't get the approval yet this year, but again we can't be certain."

Can one reconcile the 2 statements made essentially within the same timeframe?